Clinical Trial Update: Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™ [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating INTERCEED in rectal cancer surgery with preventive ileostomy; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• INTERCEED

Snippet

Sponsor: Ethicon, Inc. | Conditions: Subjects Scheduled to Undergo Laparoscopic Radical Resection of Rectal Carcinoma With Preventive Ileostomy | Phase 3 | Status: TERMINATED | Results posted: 2022-05-13